Topic

Pharmacovigilance

Pharmacovigilance covers the full lifecycle of detecting, assessing, and preventing adverse effects of medicines. Browse verified PV Bulletin updates across signal management, labeling, inspections, country compliance, and QPPV oversight — written for operational drug safety teams, not generic pharma news.

2 matching updates · Sorted by impact priority

publicTherapeutic Goods Administration (TGA) · Australia · Updated Jun 29, 2026

Summary of fees and charges to applications submitted to the TGA

Monitoring

Sponsors must prepare for increased costs tied to the submission and maintenance of products on the ARTG which will impact their regulatory budget planning and compliance processes.

Country ComplianceRegulatory Intelligence Lead

SOP Impact1 SOPs

ConfidenceHigh

Relevant for: Regulatory Intelligence Lead, QPPV

verifiedRegulatory action: Policy Update

Read impact briefarrow_forward

publicMHRA · United Kingdom · Updated Jun 29, 2026

MHRA: Updated information on the MHRA's service providing scientific and regulatory guidance to developers of innovative medical products

Monitoring

Innovators must now utilize the Innovation Accelerator for access to regulatory expertise and guidance on pharmacovigilance and risk management strategies.

Country ComplianceRegulatory Intelligence Lead

SOP Impact1 SOPs

ConfidenceHigh

Relevant for: Regulatory Intelligence Lead, QPPV

verifiedRegulatory action: Guidance

Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only